Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal testosterone for hypoactive sexual desire disorder in naturally menopausal women
2006-001179-39Phase 3Completed
- Sponsor
- Procter & Gamble
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypoactive sexual desire disorder (HSDD) comparing Testosterone transdermal system with Placebo (2 arms). Primary endpoint: Change from baseline to Week 24 in 4-week frequency of total satisfying episodes. Started Jun 2006; status: completed.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on 2006-001179-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001179-39.